New Century Health Associate Chief Medical Officer Dr. Monica Soni explores some of the most prevalent health inequities in cancer care and shares strategies for how to address them.
Other content in this Stream
New Century Health and Humana's national partnership improves patient experience and eases administrative burdens on provider practices.
How do social determinants of health impact outcomes in cancer care? New Century Health Associate CMO Dr. Monica Soni and Radiation Oncologist Dr. Onyinye Balogun discuss.
New Century Health and our Vital Decisions solution seek to ensure more cancer patients receive end-of-life care that aligns with their wishes.
New Century Health Partner Cancer Care Specialists of Illinois Earns $3.6 Million from Medicare through Federal Oncology Care Model
NCH’s high-value clinical oncology pathways, patient triage programs and provider engagement strategies help community practice to succeed in value-based payment program.
Still Bracing for the Surge in Advanced Cancer Cases
The predicted wave of late-stage cancers is taking longer to materialize than we expected.
The Pandemic's Disproportionate Impact on Health Care Disparities and Cancer
Our associate chief medical officer shares her insights with the American Journal of Managed Care's podcast.
Cancer Moonshot 2.0: Three Big Questions to Track
Which components of the recently announced Cancer Moonshot should get high priority for the initiative to succeed? Our chief medical officer, Dr. Andrew Hertler, outlines three key questions to track.
Accelerated Drug Approvals Present a Mounting Challenge to Oncologists
Dr. Andrew Hertler explains three key criteria for evaluating fast-tracked drugs.
Panel Discussion: Oncology Care Reimagined
Health plan clinical leaders joined us for an insightful discussion on the path toward high-value cancer care.
Home-based chemotherapy infusions may offer convenience but also raise a host of questions.
Shouldering the Burden and Financial Toxicity of Part D Cancer Drugs
Discussing drug costs should be a core tenet of shared decision-making.
Evidence-Based Oncology interviews our CMO about mismatches between drug costs and efficacy.
Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.
Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals
Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.
Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.
Hitting the Brakes on Fast-Tracked Drugs
The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.
New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncology specialty management services to Neighborhood Health Plan of Rhode Island.
New Century Health CMO, Dr. Andrew Hertler, shares his thoughts on the recent FDA meetings to review the merits of approved cancer drugs.
Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.